Immune Checkpoint Inhibition for Advanced Skin Cancer in Patients With Concomitant Hematological Malignancy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Immune Checkpoint Inhibition Therapy for Advanced Skin Cancer in Patients With Concomitant Hematological Malignancy: A Retrospective Multicenter DeCOG Study of 84 Patients
J Immunother Cancer 2020 Oct 01;8(2)e000897, U Leiter, C Loquai, L Reinhardt, D Rafei-Shamsabadi, R Gutzmer, K Kaehler, L Heinzerling, JC Hassel, V Glutsch, J Sirokay, N Schlecht, A Rübben, T Gambichler, K Schatton, C Pfoehler, C Franklin, P Terheyden, S Haferkamp, P Mohr, L Bischof, E Livingstone, L Zimmer, M Weichenthal, D Schadendorf, A Meiwes, U Keim, C Garbe, JC Becker, S UgurelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.